4//SEC Filing
McDonough John 4
Accession 0000899243-21-027184
CIK 0001492674other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:00 PM ET
Size
5.1 KB
Accession
0000899243-21-027184
Insider Transaction Report
Form 4
McDonough John
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2021-07-01$1.16/sh−18,182$21,091→ 516,386 total
Footnotes (2)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021, to cover payment of tax liability incident to the vesting of restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.16 to $1.19. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615937
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:00 PM ET
- Size
- 5.1 KB